ArticlePloS one2026
Effect of COVID-19 on mortality due to diabetes mellitus in Brazil: A time series analysis from 2010 to 2023.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus (DM) is a major global public health concern, particularly in Brazil. This study aimed to analyze DM-related mortality trends before and during the pandemic to assess the possible influence of the COVID-19 pandemic on DM mortality in Brazil. Mortality was assessed using standardized mortality rates stratified by age group (20-29 years, 30-49 years, 50-69 years, 70 years or older), sex (male, female), and geographic region (North, Northeast, Southeast, South, and Midwest). Mortality rates were calculated using the Brazilian Mortality Information System and official national population estimates. An analytical ecological time series analysis was performed using the Prais-Winsten regression model to assess the DM-related mortality trends in two scenarios: before (2010-2019) and including the pandemic period (2010-2023). The annual percentage change (APC) and 95% confidence intervals (CIs) were calculated to synthesize the trends as decreasing, increasing, or stationary. DM-related mortality rates varied from 42.3 in 2010 to 35.9 per 100,000 deaths in 2023, with the highest values in the Northeastern region. An increase in mortality was observed from 2020 onwards. Regression analysis shows a decreasing trend in the pre-pandemic period (2010-2019) in women (-1.87%), 50-69 years (-1.24%), and ≥70 years (-1.21%). A decline was also observed in the Northeast (-1.06%), Southeast (-1.73%), and nationwide (-0.96%). However, after incorporating data from the pandemic period (2010-2023), the trend became stationary for individuals aged 50-69 years and ≥70 years, the Southeastern region, and Brazil. This change makes the expected mortality uncertain and highlights the need for effective coping strategies after the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.